NovaBay Pharmaceuticals, Inc. Free Cash Flow Growth

Free Cash Flow Growth of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Free Cash Flow Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Free Cash Flow Growth for the quarter ending June 30, 2022 was 15.74% (a -108.82% decrease compared to previous quarter)
  • Year-over-year quarterly Free Cash Flow Growth decreased by -7254.55%
  • Annual Free Cash Flow Growth for 2021 was -133.05% (a -397.65% decrease from previous year)
  • Annual Free Cash Flow Growth for 2020 was 44.7% (a -265.49% decrease from previous year)
  • Annual Free Cash Flow Growth for 2019 was -27.01% (a -295.02% decrease from previous year)
  • Twelve month Free Cash Flow Growth ending June 30, 2022 was -87.39% (a -28.8% decrease compared to previous quarter)
  • Twelve month trailing Free Cash Flow Growth increased by 182.18% year-over-year
Trailing Free Cash Flow Growth for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
-87.39% -122.74% -95.6% -30.97%
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Free Cash Flow Growth of NovaBay Pharmaceuticals, Inc.

Most recent Free Cash Flow Growthof NBY including historical data for past 10 years.

Interactive Chart of Free Cash Flow Growth of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Free Cash Flow Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 15.74% -178.53%
2021 -212.14% -0.22% -81.27% -66.94% -133.05%
2020 -2.59% 8.33% 41.65% 73.26% 44.7%
2019 29.4% 7.75% -19.25% -594.21% -27.01%
2018 31.2% -881.73% 12.77% 77.43% 13.85%
2017 -874.17% 105.35% 36.03% 58.27% 44.89%
2016 93.39% 6.56% 50.65% -10.37% 36.6%
2015 -10.66% -49.66% -48.44% -1.26% -24.34%
2014 13.68% -15.35% -65.01% -19.64% -14.38%
2013 -50.08% -1259.13% -131.52% -35.32% -96.55%
2012 -438.92% -73.37% 71.4% -2607.92% -104.54%
2011 -128.69% 368.38% -278.68%

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology